Genzyme Oncology · Cambridge, MA United States
| 55 Cambridge Pkwy. | Phone: 617-761-8777 |
| Cambridge, MA | Fax: 617-761-8918 |
| 02142 | |
| United States |
Map This Company |
- Company Profiles
- Competitive Landscapes
- Industry Reports
Buy Reports
For a Hoover's Free Trial, Call
(866) 444-8642or
Chat NowGenzyme Oncology Rankings
Company Description
Genzyme Oncology is aiming for the jet set of the cancer therapeutics market. The company develops, manufactures, and markets traditional and gene-based cancer therapies. Its technology approaches include anti-angiogenesis, which halts the growth of blood vessels in tumors, and a program attacking cancer at the cellular level. Marketed products include Campath, for the treatment of B-cell chronic lymphocytic leukemia (B-CLL), and Clolar, which is used in the treatment of relapsed acute lymphoblastic leukemia (ALL) in children. Genzyme Oncology also develops therapeutics for hematology and immune system disorders. The company is a division of Genzyme, which was acquired by Sanofi in 2011.

Genzyme Oncology Reports

No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.

Financials
| Company Type | Business Segment |
|---|
| Fiscal Year-End | December |
|---|
Top Genzyme Oncology Competitors